ストックスクリーナーアプリを入手
385.74
1.01%
3.865
アフターアワーズ：
385.74
0.005
+0.00%
前日終値:
$381.87
開ける：
$381.91
24時間の取引高:
1.84M
Relative Volume:
1.06
時価総額：
$98.90B
収益：
$11.39B
当期純損益:
$3.64B
株価収益率:
27.57
EPS:
13.99
ネットキャッシュフロー:
$3.50B
1週間 パフォーマンス:
+0.68%
1か月 パフォーマンス:
-0.37%
6か月 パフォーマンス:
-22.90%
1年 パフォーマンス:
-16.71%
1日の値動き範囲:
$379.72
$387.48
1週間の範囲:
$374.17
$387.48
52週間の値動き範囲:
$362.50
$519.88
Vertex Pharmaceuticals Inc Stock (VRTX) Company Profile
名前
Vertex Pharmaceuticals Inc
セクター
電話
(617) 341-6393
住所
50 NORTHERN AVENUE, BOSTON, MA
VRTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Vertex Pharmaceuticals Inc Stock (VRTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-09-03 | 開始されました | Raymond James | Mkt Perform |
| 2025-08-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-05-07 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-05-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-02-12 | アップグレード | Canaccord Genuity | Sell → Hold |
| 2025-02-11 | アップグレード | Canaccord Genuity | Sell → Hold |
| 2025-01-30 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-12-19 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-12-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-08-05 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-06-27 | 開始されました | Redburn Atlantic | Buy |
| 2024-04-11 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2024-02-06 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-02-02 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-01-31 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2024-01-24 | ダウングレード | Canaccord Genuity | Hold → Sell |
| 2023-12-14 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2023-05-30 | 開始されました | William Blair | Outperform |
| 2023-05-04 | 再開されました | Piper Sandler | Overweight |
| 2023-03-21 | 開始されました | Bernstein | Outperform |
| 2023-01-18 | 開始されました | Canaccord Genuity | Hold |
| 2023-01-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-12-19 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-06-01 | アップグレード | Maxim Group | Hold → Buy |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-05-06 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-03 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2022-02-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-01-27 | 繰り返されました | JP Morgan | Overweight |
| 2022-01-27 | 繰り返されました | Morgan Stanley | Underweight |
| 2022-01-27 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Hold |
| 2022-01-27 | 繰り返されました | Wolfe Research | Outperform |
| 2022-01-20 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-19 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-09-09 | ダウングレード | Stifel | Buy → Hold |
| 2021-09-07 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2021-07-20 | ダウングレード | SVB Leerink | Mkt Perform → Underperform |
| 2021-07-19 | 再開されました | Wolfe Research | Outperform |
| 2021-07-01 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-11 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-02-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-02-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-30 | 開始されました | Daiwa Securities | Outperform |
| 2020-11-30 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-20 | 開始されました | Bernstein | Outperform |
| 2020-10-28 | 開始されました | UBS | Buy |
| 2020-07-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-28 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-11-19 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-10-17 | 再開されました | BofA/Merrill | Buy |
| 2019-09-03 | アップグレード | Goldman | Neutral → Buy |
| 2019-08-01 | ダウングレード | Needham | Buy → Hold |
| 2019-05-23 | 再開されました | Citigroup | Buy |
| 2019-05-21 | 開始されました | Credit Suisse | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | In-line |
| 2019-03-26 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2019-03-19 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-02-06 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline - Yahoo Finance
Perigon Wealth Management LLC Boosts Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
State of Alaska Department of Revenue Lowers Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True? - Nasdaq
Leerink Partnrs Issues Pessimistic Outlook for VRTX Earnings - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by Leerink Partnrs to Strong-Buy Rating - MarketBeat
TD Private Client Wealth LLC Cuts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Banque Pictet & Cie SA - MarketBeat
Trump’s 100% Drug Tariff Bombshell: Which Pharma Stocks Would Soar or Crash? - Investing.com
Key advancements across Vertex’ kidney portfolio - The Pharma Letter
Vertex Pharmaceuticals’ Strategic Acquisition and FDA Breakthrough Designation Boosts Buy Rating - TipRanks
Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership - Seeking Alpha
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by Leerink Partners to Outperform Rating - MarketBeat
Vertex Pharmaceuticals completes enrollment in IA cohort of AMPLITUDE trial - TipRanks
Leerink Partners Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq
Vertex Announces Key Advancements Across Kidney Portfolio - Yahoo Finance
This Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Vertex stock rating upgraded to Outperform by Leerink Partners on pain drug outlook - Investing.com
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Leerink Partners Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjusts PT to $456 From $458 - MarketScreener
Leerink ups Vertex Pharmaceuticals to Outperform on stock pullback, solid growth - TipRanks
Beacon Investment Advisory Services Inc. Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
4,352 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by Harrell Investment Partners LLC - MarketBeat
Biotech Stocks To Follow TodaySeptember 21st - MarketBeat
Norden Group LLC Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha
Vertex secures all-star assist for Journavx, signing up NBA's Jayson Tatum for pain drug promotion - Fierce Pharma
Foster Victor Wealth Advisors LLC Boosts Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Public Employees Retirement System of Ohio Has $47.22 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals: Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by CCM Investment Advisers LLC - MarketBeat
Promising Biotech Stocks To ConsiderSeptember 20th - MarketBeat
Sovran Advisors LLC Has $646,000 Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Sells 25,740 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Assenagon Asset Management S.A. Purchases 34,614 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Avanza Fonder AB Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
IFM Investors Pty Ltd Purchases 1,781 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Kingstone Capital Partners Texas LLC Invests $23.87 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Atle Fund Management AB Purchases 1,520 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Wealth Enhancement Advisory Services LLC - MarketBeat
Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX - Business Wire
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Wedmont Private Capital - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Baader Bank Aktiengesellschaft - MarketBeat
Andrew Hill Investment Advisors Inc. Purchases 1,430 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks - Yahoo Finance
Channel Wealth LLC Acquires 11,833 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
UMB Bank n.a. Sells 1,094 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Trims Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (VRTX) 財務データ
収益
当期純利益
現金流量
EPS
1.51%
0.71%
大文字化:
|
ボリューム (24 時間):